Showing 105,941 - 105,951 results of 105,951 for search '(( 3 point decrease ) OR ( 5 ((((step decrease) OR (we decrease))) OR (a decrease)) ))', query time: 1.82s Refine Results
  1. 105941

    Table1_Tolerability, safety, and pharmacokinetics of a single intravenous administration of a novel recombinant humanized anti-interleukin-6 receptor monoclonal antibody in healthy... by Xin Jiang (6348)

    Published 2024
    “…Samples for pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity were collected at specified time points and analyzed through validated methods. Adverse events and the results of the examination and laboratory were analyzed to assess the safety profile.…”
  2. 105942

    DataSheet_1_Differential analysis of transcriptomic and metabolomic of free fatty acid rancidity process in oil palm (Elaeis guineensis) fruits of different husk types.doc by Shuyan Zhang (426593)

    Published 2023
    “…FATB fluctuates unevenly in MT and MP, with the level of expression growing steadily in MT and decreasing in MP before increasing. The amount of SDR gene expression varies in opposite directions in both shell types. …”
  3. 105943

    Mode of virus transmission differentially steers susceptibility to entry inhibition. by Irene A. Abela (173068)

    Published 2012
    “…Red and black values denote IC50 (nM) of during cell-cell and cell-free transmission, respectively. Data points represent means of duplicates from three independent inhibition experiments. …”
  4. 105944

    Table_1_Association between dietary approaches to stop hypertension eating pattern and lung cancer risk in 98,459 participants: results from a large prospective study.docx by Zhiyong Zhu (2559349)

    Published 2023
    “…The mean (standard deviation) DASH score was 24.00 (4.62) points, along with the mean follow-up period of 8.84 (1.94) years. …”
  5. 105945

    Table_S2_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX by Flavia Ismael (6426614)

    Published 2021
    “…After this phase (median = 108 days after intake, IQR = 76–137), we asked these patients who were classified as experiencing mild COVID-19 (n = 993) about last-month substance use in three time-points: pre-COVID, just after COVID-19 acute phase (post-COVID acute phase) and in the period before survey (post-COVID follow-up phase).…”
  6. 105946

    Table_2_Association between dietary approaches to stop hypertension eating pattern and lung cancer risk in 98,459 participants: results from a large prospective study.DOCX by Zhiyong Zhu (2559349)

    Published 2023
    “…The mean (standard deviation) DASH score was 24.00 (4.62) points, along with the mean follow-up period of 8.84 (1.94) years. …”
  7. 105947

    Table_S1_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX by Flavia Ismael (6426614)

    Published 2021
    “…After this phase (median = 108 days after intake, IQR = 76–137), we asked these patients who were classified as experiencing mild COVID-19 (n = 993) about last-month substance use in three time-points: pre-COVID, just after COVID-19 acute phase (post-COVID acute phase) and in the period before survey (post-COVID follow-up phase).…”
  8. 105948

    Table_S2_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX by Flavia Ismael (6426614)

    Published 2021
    “…After this phase (median = 108 days after intake, IQR = 76–137), we asked these patients who were classified as experiencing mild COVID-19 (n = 993) about last-month substance use in three time-points: pre-COVID, just after COVID-19 acute phase (post-COVID acute phase) and in the period before survey (post-COVID follow-up phase).…”
  9. 105949

    Table_S1_Substance Use in Mild-COVID-19 Patients: A Retrospective Study.XLSX by Flavia Ismael (6426614)

    Published 2021
    “…After this phase (median = 108 days after intake, IQR = 76–137), we asked these patients who were classified as experiencing mild COVID-19 (n = 993) about last-month substance use in three time-points: pre-COVID, just after COVID-19 acute phase (post-COVID acute phase) and in the period before survey (post-COVID follow-up phase).…”
  10. 105950

    Design of an inducible CRISPRi gene-silencing system for <i>S</i>. <i>mutans</i>. by Robert C. Shields (8551326)

    Published 2020
    “…As the xylose concentration was decreased, data points change from a dark to a light blue color. …”
  11. 105951

    Interaction between tombusvirus replication proteins and Pdc1 fermentation enzyme. by Wenwu Lin (7542863)

    Published 2019
    “…Each experiment was repeated three times.</p>…”